1. Cotrimoxazole

   Case report 05 October 2013 Pages: 15 - 15

2. Cotrimoxazole

   Case report 05 October 2013 Pages: 15 - 15

3. Collagenase clostridium histolyticum

   Case report 05 October 2013 Pages: 15 - 15

4. Cytarabine/methotrexate/vincristine

   Case report 05 October 2013 Pages: 16 - 16

5. Dabigatran etexilate

   Case report 05 October 2013 Pages: 16 - 16

6. Cyclophosphamide/doxorubicin/prednisolone

   Case report 05 October 2013 Pages: 16 - 16

7. Cyclophosphamide/epirubicin

   Case report 05 October 2013 Pages: 16 - 16

8. Dasatinib

   Case report 05 October 2013 Pages: 17 - 17

9. Deferiprone

   Case report 05 October 2013 Pages: 17 - 17

10. Dantrolene

    Case report 05 October 2013 Pages: 17 - 17

11. Diazepam

    Case report 05 October 2013 Pages: 17 - 17

12. Dibotermin-α

    Case report 05 October 2013 Pages: 18 - 18

13. Donepezil

    Case report 05 October 2013 Pages: 18 - 18

14. Diazoxide

    Case report 05 October 2013 Pages: 18 - 18

15. Docetaxel

    Case report 05 October 2013 Pages: 18 - 18

16. Estradiol/progesterone

    Case report 05 October 2013 Pages: 19 - 19

17. Epinephrine

    Case report 05 October 2013 Pages: 19 - 19

18. Entecavir

    Case report 05 October 2013 Pages: 19 - 19

19. Erlotinib

    Case report 05 October 2013 Pages: 19 - 19

20. Etanercept

    Case report 05 October 2013 Pages: 20 - 20

21. Everolimus

    Case report 05 October 2013 Pages: 20 - 20

22. Estrogen/leuprorelin

    Case report 05 October 2013 Pages: 20 - 20

23. Everolimus

    Case report 05 October 2013 Pages: 20 - 20

24. Everolimus/mitotane interaction

    Case report 05 October 2013 Pages: 20 - 20

25. Fingolimod

    Case report 05 October 2013 Pages: 21 - 21

26. Fentanyl/methadone

    Case report 05 October 2013 Pages: 21 - 21

27. Factor XI

    Case report 05 October 2013 Pages: 21 - 21

28. Flecainide overdose

    Case report 05 October 2013 Pages: 21 - 21

29. Gabapentin

    Case report 05 October 2013 Pages: 22 - 22

30. Fluconazole

    Case report 05 October 2013 Pages: 22 - 22

31. Gefitinib

    Case report 05 October 2013 Pages: 22 - 22

32. Heparin

    Case report 05 October 2013 Pages: 22 - 22

33. Imatinib

    Case report 05 October 2013 Pages: 23 - 23

34. Ibandronic acid

    Case report 05 October 2013 Pages: 23 - 23

35. Ibandronic acid

    Case report 05 October 2013 Pages: 23 - 23

36. Hyaluronidase

    Case report 05 October 2013 Pages: 23 - 23

37. Imatinib

    Case report 05 October 2013 Pages: 24 - 24

38. Influenza virus vaccine

    Case report 05 October 2013 Pages: 24 - 24

39. Iodine/peginterferon-α

    Case report 05 October 2013 Pages: 24 - 24

40. Immune globulin

    Case report 05 October 2013 Pages: 24 - 24

41. Lenalidomide

    Case report 05 October 2013 Pages: 25 - 25

42. Lamivudine/nevirapine/zidovudine

    Case report 05 October 2013 Pages: 25 - 25

43. Leflunomide

    Case report 05 October 2013 Pages: 25 - 25

44. Lamotrigine

    Case report 05 October 2013 Pages: 25 - 25

45. Ivermectin

    Case report 05 October 2013 Pages: 25 - 25

46. Levodopa

    Case report 05 October 2013 Pages: 26 - 26

47. Linezolid

    Case report 05 October 2013 Pages: 26 - 26

48. Lithium

    Case report 05 October 2013 Pages: 26 - 26

49. Levetiracetam

    Case report 05 October 2013 Pages: 26 - 26

50. Lithium/venlafaxine

    Case report 05 October 2013 Pages: 26 - 26